脊髓损伤的跨性别女性性别肯定治疗的细微差别。
Nuances of gender affirming therapy for transgender women with spinal cord injury.
作者信息
Claus Deanna, Etter Darryl, Ryder Stephanie Cowherd
机构信息
Physical Medicine and Rehabilitation, University of Colorado, Aurora, CO, USA.
Spinal Cord Injury and Disorders Center, Rocky Mountain Regional Veteran's Affairs Hospital, Aurora, CO, USA.
出版信息
J Spinal Cord Med. 2025 May;48(3):542-544. doi: 10.1080/10790268.2024.2396644. Epub 2024 Sep 3.
Abstract
CASE DESCRIPTION
56-year-old transgender woman with new spinal cord injury (SCI) on gender affirming hormonal therapy (GAHT) with estrogen and spironolactone.
FINDINGS
After her injury, estrogen and spironolactone were discontinued, for blood clots and hypotension, respectively. Alternative options were explored.
CLINICAL RELEVANCE
Little is known about GAHT in SCI for transgender women. Shared decision making should be used to navigate risks, benefits, and alternative options.
摘要
病例描述
一名56岁的跨性别女性，在接受雌激素和螺内酯的性别确认激素治疗（GAHT）时发生了新的脊髓损伤（SCI）。
检查结果
受伤后，分别因血栓和低血压停用了雌激素和螺内酯。探索了其他选择。
临床意义
对于跨性别女性脊髓损伤患者的性别确认激素治疗了解甚少。应采用共同决策来权衡风险、益处和替代方案。
相似文献
1
Nuances of gender affirming therapy for transgender women with spinal cord injury.脊髓损伤的跨性别女性性别肯定治疗的细微差别。
J Spinal Cord Med. 2025 May;48(3):542-544. doi: 10.1080/10790268.2024.2396644. Epub 2024 Sep 3.
2
Effects of gender affirming hormone therapy with testosterone on renal function of assigned female at birth transgender people: a meta-analysis.睾酮性别肯定激素疗法对出生时被指定为女性的跨性别者肾功能的影响：一项荟萃分析。
Front Endocrinol (Lausanne). 2025 Jun 12;16:1537838. doi: 10.3389/fendo.2025.1537838. eCollection 2025.
3
Injectable Aesthetic Treatments for Improving Facial Skin Quality in Transgender Patients With or Without Gender-Affirming Hormone Therapy.用于改善接受或未接受性别确认激素治疗的跨性别患者面部皮肤质量的注射美容治疗
J Cosmet Dermatol. 2025 Sep;24 Suppl 4(Suppl 4):e70318. doi: 10.1111/jocd.70318.
4
Prevalence of detransition in persons seeking gender-affirming hormonal treatments: a systematic review.寻求性别肯定激素治疗者中性别转变的发生率：一项系统综述。
J Sex Med. 2025 Jan 9;22(2):356-368. doi: 10.1093/jsxmed/qdae186.
5
The attitudes of transgender and gender-diverse adolescents and their parents regarding fertility, parenthood, and fertility preservation before the start of puberty suppression or gender-affirming hormone therapy.跨性别和性别多样化青少年及其父母在开始青春期抑制或性别确认激素治疗之前，对生育、为人父母和生育力保存的态度。
J Sex Med. 2025 May 10;22(5):924-936. doi: 10.1093/jsxmed/qdaf029.
6
Gender-Affirming Hormone Therapy and Depressive Symptoms Among Transgender Adults.成年跨性别者的性别肯定激素治疗与抑郁症状
JAMA Netw Open. 2025 Mar 3;8(3):e250955. doi: 10.1001/jamanetworkopen.2025.0955.
7
Development of a large Danish single-centre retro- and prospective transgender cohort using a web-based platform: a study protocol of a transgender cohort study.利用基于网络的平台建立丹麦大型单中心回顾性和前瞻性跨性别队列：一项跨性别队列研究的研究方案
BMJ Open. 2025 Jun 9;15(6):e091366. doi: 10.1136/bmjopen-2024-091366.
8
Association Between Gender-affirming Hormone Therapy and Measures of Glucose Metabolism: A Longitudinal Study.性别确认激素疗法与葡萄糖代谢指标之间的关联：一项纵向研究。
J Clin Endocrinol Metab. 2024 Dec 18;110(1):289-296. doi: 10.1210/clinem/dgae353.
9
Continuation of Gender-Affirming Hormone Therapy in Transgender and Gender-Diverse Individuals: A Systematic Review.跨性别和性别多样化个体中性别确认激素治疗的延续性：一项系统综述
Endocr Pract. 2024 Dec;30(12):1206-1211. doi: 10.1016/j.eprac.2024.09.007. Epub 2024 Sep 19.
10
Transgender-Affirming Hormone Therapies, QT Prolongation, and Cardiac Repolarization.跨性别者肯定性激素疗法、QT间期延长与心脏复极化
JAMA Netw Open. 2025 Jul 1;8(7):e2524124. doi: 10.1001/jamanetworkopen.2025.24124.
本文引用的文献
1
How Should a Transgender Patient's History of Deep Vein Thrombosis and Smoking Influence Gender-Affirming Health Decision Sharing? transgender 患者的深静脉血栓形成和吸烟史如何影响性别肯定健康决策共享？
AMA J Ethics. 2023 Jun 1;25(6):E386-390. doi: 10.1001/amajethics.2023.386.
2
Assessing and Addressing the Risk of Venous Thromboembolism Across the Spectrum of Gender Affirming Care: A Review.评估和应对跨性别肯定护理谱中的静脉血栓栓塞风险：综述。
Endocr Pract. 2023 Apr;29(4):272-278. doi: 10.1016/j.eprac.2022.12.008. Epub 2022 Dec 17.
3
Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.跨性别和性别多样化人群的性别肯定激素治疗：治疗方式、监测和风险概述。
Neurourol Urodyn. 2023 Jun;42(5):903-920. doi: 10.1002/nau.25097. Epub 2022 Nov 20.
4
Health and Health Care Among Transgender Adults in the United States.美国跨性别成年人的健康与医疗保健
Annu Rev Public Health. 2022 Apr 5;43:503-523. doi: 10.1146/annurev-publhealth-052620-100313. Epub 2021 Dec 9.
5
Spinal cord injury in sexual and gender minority individuals.性少数群体和性别少数群体中的脊髓损伤
J Spinal Cord Med. 2021 Sep;44(5):687-689. doi: 10.1080/10790268.2021.1970886.
6
A Primary Care Provider's Guide to Social Justice, the Right to Care, and the Barriers to Access After Spinal Cord Injury.初级医疗服务提供者的社会正义指南：脊髓损伤后的就医权与就医障碍
Top Spinal Cord Inj Rehabil. 2020 Spring;26(2):85-90. doi: 10.46292/sci2602-85.
7
Discrimination in the United States: Experiences of lesbian, gay, bisexual, transgender, and queer Americans.美国的歧视：女同性恋、男同性恋、双性恋、跨性别和酷儿美国人的经历。
Health Serv Res. 2019 Dec;54 Suppl 2(Suppl 2):1454-1466. doi: 10.1111/1475-6773.13229. Epub 2019 Oct 28.
8
Acute Clinical Care for Transgender Patients: A Review. transgender 患者的急性临床护理：综述。
JAMA Intern Med. 2018 Nov 1;178(11):1535-1543. doi: 10.1001/jamainternmed.2018.4179.
9
Hormone replacement therapy in women with spinal cord injury - a survey with literature review.
Spinal Cord. 2005 Feb;43(2):67-73. doi: 10.1038/sj.sc.3101694.
Zotero 插件